Overactive Bladder clinical trials at UC Irvine

3 in progress, 2 open to eligible people

Showing trials for

  • Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)

    open to eligible people ages 18 years and up

    A prospective, multicenter, single-arm study to evaluate the safety and effectiveness of the eCoin® implanted tibial nerve stimulator in subjects with urgency urinary incontinence (UUI).

    Irvine, California and other locations

  • CAN-Stim Compared to SNS in Treatment of Urinary Urgency Incontinence With Wireless Neuromodulation Technology

    open to eligible people ages 18 years and up

    This is a prospective, randomized, controlled, multi-center, study in which 150 evaluable subjects will be randomized 1:1 to receive either a Protect CAN-Stim or SNS InterStim® system. Subjects from both groups will immediately start with therapy. The primary endpoint is a ≥ 50% reduction in number of incontinence episodes associated with urgency at the 3-month visit, with additional measurements assessed at 14 days, 1, 6, 9 and 12-months.

    Orange, California and other locations

  • BlueWind RENOVA iStim™ System for the Treatment of OAB

    Sorry, not currently recruiting here

    The OASIS study is prospective, interventional, multi-center study to evaluate the safety and efficacy of the BlueWind RENOVA iStim™ implantable tibial neuromodulation System for the treatment of patients diagnosed with overactive bladder.

    Orange, California and other locations

Our lead scientists for Overactive Bladder research studies include .

Last updated: